# Effects of a Goal-directed Hemodynamic Therapy Driven by ECOM on Morbidity and Mortality After Cardiac Surgery?

> **NCT01535716** · PHASE4 · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 100 (actual)

## Conditions studied

- Coronary Surgery With Cardiopulmonary Bypass

## Interventions

- **BEHAVIORAL:** hemodynamic optimization strategy driven by the ECOM
- **BEHAVIORAL:** standard management strategy

## Key facts

- **NCT ID:** NCT01535716
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01535716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01535716, "Effects of a Goal-directed Hemodynamic Therapy Driven by ECOM on Morbidity and Mortality After Cardiac Surgery?". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01535716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
